BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33544979)

  • 1. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program.
    Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE
    Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmethylated Mosaic Full Mutation Males without Fragile X Syndrome.
    Tak Y; Schneider A; Santos E; Randol JL; Tassone F; Hagerman P; Hagerman RJ
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of molecular approach in screening for fragile X premutation cases.
    Refeat MM; El Saied MM; Abdel Raouf ER
    Ir J Med Sci; 2023 Oct; 192(5):2265-2272. PubMed ID: 36409419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FMR1 gene and fragile X-associated tremor/ataxia syndrome.
    Brouwer JR; Willemsen R; Oostra BA
    Am J Med Genet B Neuropsychiatr Genet; 2009 Sep; 150B(6):782-98. PubMed ID: 19105204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue mosaicism, FMR1 expression and intellectual functioning in males with fragile X syndrome.
    Baker EK; Arpone M; Bui M; Kraan CM; Ling L; Francis D; Hunter MF; Rogers C; Field MJ; Santa María L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
    Am J Med Genet A; 2023 Feb; 191(2):357-369. PubMed ID: 36349505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAN translation at CGG repeats induces ubiquitin proteasome system impairment in models of fragile X-associated tremor ataxia syndrome.
    Oh SY; He F; Krans A; Frazer M; Taylor JP; Paulson HL; Todd PK
    Hum Mol Genet; 2015 Aug; 24(15):4317-26. PubMed ID: 25954027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for
    Hnoonual A; Jankittunpaiboon C; Limprasert P
    Biomed Res Int; 2021; 2021():4359308. PubMed ID: 34926684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FMR1 Protein Expression Correlates with Intelligence Quotient in Both Peripheral Blood Mononuclear Cells and Fibroblasts from Individuals with an FMR1 Mutation.
    Jiraanont P; Zafarullah M; Sulaiman N; Espinal GM; Randol JL; Durbin-Johnson B; Schneider A; Hagerman RJ; Hagerman PJ; Tassone F
    J Mol Diagn; 2024 Jun; 26(6):498-509. PubMed ID: 38522837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of CGG-repeats alters ovarian response to gonadotropins and leads to infertility in a murine FMR1 premutation model.
    Shelly KE; Candelaria NR; Li Z; Allen EG; Jin P; Nelson DL
    Hum Mol Genet; 2021 May; 30(10):923-938. PubMed ID: 33856019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene.
    Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R
    Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction, nuclease digestion, and mass spectrometry based assay for the trinucleotide repeat status of the fragile X mental retardation 1 gene.
    Dodds ED; Tassone F; Hagerman PJ; Lebrilla CB
    Anal Chem; 2009 Jul; 81(13):5533-40. PubMed ID: 19514725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of FMRP Expression in Peripheral Blood Mononuclear Cells from Individuals with Fragile X Syndrome.
    Randol JL; Kim K; Ponzini MD; Tassone F; Falcon AK; Hagerman RJ; Hagerman PJ
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CTCF protein in regulating FMR1 locus transcription.
    Lanni S; Goracci M; Borrelli L; Mancano G; Chiurazzi P; Moscato U; Ferrè F; Helmer-Citterich M; Tabolacci E; Neri G
    PLoS Genet; 2013; 9(7):e1003601. PubMed ID: 23874213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel epigenetic marker for typical and mosaic presentations of Fragile X syndrome.
    da Silva CP; Camuzi D; Reis AHO; Gonçalves AP; Dos Santos JM; Machado FB; Medina-Acosta E; Soares-Lima SC; Santos-Rebouças CB
    Expert Rev Mol Diagn; 2023; 23(12):1273-1281. PubMed ID: 37970883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X syndrome and associated disorders: Clinical aspects and pathology.
    Salcedo-Arellano MJ; Dufour B; McLennan Y; Martinez-Cerdeno V; Hagerman R
    Neurobiol Dis; 2020 Mar; 136():104740. PubMed ID: 31927143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).
    Zafarullah M; Palczewski G; Rivera SM; Hessl DR; Tassone F
    FASEB J; 2020 Dec; 34(12):16676-16692. PubMed ID: 33131090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice.
    Foote M; Arque G; Berman RF; Santos M
    Cerebellum; 2016 Oct; 15(5):611-22. PubMed ID: 27255703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on
    Tassone F; Protic D; Allen EG; Archibald AD; Baud A; Brown TW; Budimirovic DB; Cohen J; Dufour B; Eiges R; Elvassore N; Gabis LV; Grudzien SJ; Hall DA; Hessl D; Hogan A; Hunter JE; Jin P; Jiraanont P; Klusek J; Kooy RF; Kraan CM; Laterza C; Lee A; Lipworth K; Losh M; Loesch D; Lozano R; Mailick MR; Manolopoulos A; Martinez-Cerdeno V; McLennan Y; Miller RM; Montanaro FAM; Mosconi MW; Potter SN; Raspa M; Rivera SM; Shelly K; Todd PK; Tutak K; Wang JY; Wheeler A; Winarni TI; Zafarullah M; Hagerman RJ
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular characteristics of FMR1 microdeletion in patient with fragile X syndrome and review of the literature.
    Hnoonual A; Plong-On O; Worachotekamjorn J; Charalsawadi C; Limprasert P
    Clin Chim Acta; 2024 Jan; 553():117728. PubMed ID: 38142803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.